Bridgeway Capital Management, LLC Brooklyn Immuno Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.48 - $2.03 $60,000 - $253,749	-125,000 Reduced 90.78%	12,700 $7,000
Q1 2022 May 16, 2022	BUY	$1.76 - $4.84 $242,352 - $666,468	137,700 New	137,700 $282,000
Q3 2021 Nov 15, 2021	SELL	$8.86 - $17.05 $132,900 - $255,750	-15,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.75 - $78.5 $9,375 - $196,250	-2,500 Reduced 14.29%	15,000 $270,000
Q1 2021 May 17, 2021	BUY	$3.72 - $12.76 $65,100 - $223,300	17,500 New	17,500 $65,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.